España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Bio-Rad Laboratories
BIO
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$352.48
-8.06
-2.24%
At close: -
$352.48
0.00
0.00%
After Hours: 4:00 PM EDT
Get Report
Comment
Bio-Rad Laboratories (BIO) Forecast
News
Earnings
Bio-Rad Laboratories (BIO) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Bio-Rad Laboratories (NYSE:BIO) Stock
Bio-Rad Laboratories Stock (NYSE: BIO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, January 21, 2025
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Tuesday, January 14, 2025
The Analyst Verdict: Bio-Rad Laboratories In The Eyes Of 4 Experts
Benzinga Insights
RBC Capital Reiterates Outperform on Bio-Rad ...
Benzinga Newsdesk
Monday, December 09, 2024
RBC Capital Maintains Outperform on Bio-Rad L...
Benzinga Newsdesk
Monday, November 04, 2024
CORRECTION: Bioage Labs Ticker Is "BIOA"
Benzinga Newsdesk
Friday, November 01, 2024
Bio-Rad Laboratories shares are trading highe...
Benzinga Newsdesk
Thursday, October 31, 2024
Citigroup Maintains Buy on Bio-Rad Laboratori...
Benzinga Newsdesk
RBC Capital Maintains Outperform on Bio-Rad L...
Benzinga Newsdesk
Bio-Rad Laboratories shares are trading highe...
Benzinga Newsdesk
Wednesday, October 30, 2024
Bio-Rad Laboratories Q3 2024 Adj. EPS $2.01 B...
Benzinga Newsdesk
Tuesday, October 01, 2024
Expert Ratings For Bio-Rad Laboratories
Benzinga Insights
Citigroup Upgrades Bio-Rad Laboratories to Bu...
Benzinga Newsdesk
Thursday, September 26, 2024
S&P 500 Shake-Up: New Entrants Driving Market Momentum
MarketBeat
Thursday, September 12, 2024
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF?
Zacks
Monday, September 09, 2024
Palantir Stock Soars After S&P 500 Inclusion, AI Deal With BP Fuels Additional Gains – What's Next?
Surbhi Jain
Friday, September 06, 2024
Palantir Technologies, Dell Technologies, And...
Benzinga Newsdesk
Tuesday, August 27, 2024
Wells Fargo Initiates Coverage On Bio-Rad Lab...
Benzinga Newsdesk
Tuesday, August 20, 2024
Bio-Rad Appoints Jon DiVincenzo As President ...
Benzinga Newsdesk
Friday, August 16, 2024
RBC Capital Reiterates Outperform on Bio-Rad ...
Benzinga Newsdesk
Monday, August 12, 2024
Bio-Rad Faces Low BioPharma Demand, Competitive Pressure
Zacks
Friday, August 02, 2024
RBC Capital Maintains Outperform on Bio-Rad L...
Benzinga Newsdesk
Citigroup Maintains Neutral on Bio-Rad Labora...
Benzinga Newsdesk
Thursday, August 01, 2024
Bio-Rad Expects FY24 Non-GAAP Revenue To Decl...
Benzinga Newsdesk
Bio-Rad Laboratories Q2 2024 Adj. EPS $3.11 B...
Benzinga Newsdesk
Sunday, June 30, 2024
S&P 500 Ends First Half Shy Of All-Time Highs. Here Are The Leaders And Laggards — And 5 Stocks That Could Outperform In Next 6 Months
Shanthi Rexaline
Monday, June 03, 2024
Jefferies Assumes Bio-Rad Laboratories at Hol...
Benzinga Newsdesk
Friday, May 17, 2024
Federal Register Reported FDA Announcing Revocation Of EUAs Issued To Bio-Rad Laboratories For The Bio-Rad Sars-Cov-2 DDPCR Kit
Charles Gross
Wednesday, May 08, 2024
The Analyst Landscape: 4 Takes On Bio-Rad Laboratories
Benzinga Insights
UBS Maintains Buy on Bio-Rad Laboratories, Lo...
Benzinga Newsdesk
Tuesday, May 07, 2024
Bio-Rad Maintains Its FY24 Financial Outlook
Benzinga Newsdesk
Bio-Rad Laboratories Q1 2024 Adj EPS $2.29 Be...
Benzinga Newsdesk
Tuesday, April 23, 2024
Shares of life sciences tools stocks are trad...
Benzinga Newsdesk
Monday, April 22, 2024
Bio-Rad Laboratories Inc Reports 8.99% Passiv...
Benzinga Newsdesk
Thursday, April 18, 2024
96% Of S&P 500 Stocks Show Upside Potential Vs. Street Estimates: Which Offers The Best Opportunity?
Piero Cingari
Thursday, April 11, 2024
Oncocyte Announces Partnership Agreement With...
Benzinga Newsdesk
Wednesday, April 10, 2024
Bio-Rad Laboratories Says Andrew Last, Execut...
Benzinga Newsdesk
Wednesday, April 03, 2024
Citigroup Downgrades Bio-Rad Laboratories to ...
Benzinga Newsdesk
Wednesday, March 20, 2024
Bio-Rad Appoints Roop Lakkaraju As Executive ...
Benzinga Newsdesk
Friday, February 16, 2024
Tech Stocks Ease On Hot PPI, Yields Rise, Microsoft, Amazon Snap 5-Week Positive Streak: What's Driving Markets Friday?
Piero Cingari
Bio-Rad Laboratories shares are trading highe...
Benzinga Newsdesk
RBC Capital Maintains Outperform on Bio-Rad L...
Benzinga Newsdesk
Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Thursday, February 15, 2024
Bio-Rad Laboratories: Q4 Earnings Insights
Benzinga Insights
Bio-Rad Laboratories Sees FY24 Non-GAAP Curre...
Benzinga Newsdesk
Bio-Rad Laboratories Q4 2023 Adj EPS $3.10 Be...
Benzinga Newsdesk
Earnings Scheduled For February 15, 2024
Benzinga Insights
Wednesday, February 14, 2024
Preview: Bio-Rad Laboratories's Earnings
Benzinga Insights
Friday, January 26, 2024
Shares of lifesciences and medical equipment ...
Benzinga Newsdesk
Tuesday, January 23, 2024
10 S&P 500 Stocks With Over 40% Upside Potential: Hidden Gems Or Value Traps?
Piero Cingari
Thursday, December 07, 2023
S&P 500's Hidden Gems: 27 Stocks With 30%+ Upside Potential According To Wall Street Analyst Targets
Piero Cingari
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch